Back to Search

RPRX

Royalty Pharma plc Class A Ordinary Shares
Data: 2026-11-11
$70.01
Price
0.81%
Change
$70.27
52W High
$37.31
52W Low
Full AI Analysis Buy/Sell Forecast Trendline Why Moving Charts Options
Analyzing positioning… Options positioning — based on yesterday's biggest open-interest changes See the chart Institutional flows
Track record
signal day → next-day price move
Quick Stats
Nov 11, 2026

36.2

AI Score

EXTENDED

1.06

Volume Ratio

TBA

Next Earnings

18

+ve Days (30d)

12

-ve Days (30d)

RPRX Price vs Max Options Open Interest

How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.

RPRX Max Change In Options Open Interest

How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.

RPRX Options - Sort by Max open Interest (near term)

12th November 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

RPRX Daily Out of Money Options - Sort by Max open Interest (near term)

12th November 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

RPRX Daily In the Money Options - Sort by Max open Interest (near term)

12th November 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

RPRX Most Active Options by Volume(near term)

12th November 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track
RPRX Technical Chart Pro Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select an indicator above — it will be added as a pane under the price chart with aligned dates.

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

RPRX Stock Summary

Last updated Nov 11, 2026

RPRX is currently trading at $70.01, positioned above its 200-day moving average of $54.34, indicating a long-term uptrend. The stock has a 52-week range of $37.31 to $70.27.

Technical Analysis: The 50-day moving average stands at $61.29, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 79.114, suggesting the stock is in overbought territory (bullish but caution advised).

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.18, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates RPRX at 36.2/100 with a EXTENDED recommendation.

RPRX (Royalty Pharma plc Class A Ordinary Shares) Indicators

Last updated Nov 11, 2026

Indicator Value
RSI(14) 79.114
CMF (20) 0.18
ROC (10) 8.007
ADX (14) 39.105
Indicator Value
MACD (12,26,9) 2.525
AROONOSC (14) 100.0
WILLAMS %R (14) -3.581
MFI (14) 74.047

RPRX Candlestick Patterns

No validated candlestick patterns fired for RPRX in the last 10 sessions — that's normal. Only the ~15 patterns with a backtested edge (out of 60 textbook patterns) are tracked here.

Royalty Pharma plc Class A Ordinary Shares is above both the 50 Day and 200 Day SMA which is considered Bullish.

RPRX Moving Averages Analysis

Royalty Pharma plc Class A Ordinary Shares has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Nov 11, 2026

Royalty Pharma plc Class A Ordinary Shares has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Nov 11, 2026

RPRX (Royalty Pharma plc Class A Ordinary Shares) Simple Moving Averages

Moving Averages are last updated Nov 11, 2026

Days MA
10 67.67
20 65.22
30 62.52
50 61.29
100 59.85
200 54.34

RPRX Fundamental Analysis

P/E (Forward) 34.0136
P/E (Trailing) 45.3922
Market Cap ($) 39.9 billion
Earnings/Share ($) 1.53
Net Profit Margin (%) 0.257
Dividend/Share ($) 0.925
EPS Estimate Current Year ($) 5.3929
EPS Estimate Next Year ($) 5.9113
WallStreet Target Price ($) 72.00
Most Recent Quarter

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.